Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - INTEREST INCOME & EXPENSE
Interest Income & Expense CHRS - Coherus BioSciences, Inc.
40.5 M
LAST VALUE
32.89%
2 YEAR CAGR
33.16%
5 YEAR CAGR
22.58%
10 YEAR CAGR